The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants

Michael Mauer, Keith Drummond

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

This report describes the design and baseline demographic and clinical data in the study of the early natural history of diabetic nephropathy (DN) in type 1 diabetes carried out by the International Diabetic Nephropathy Study Group. The study enrolled 243 patients ages 10-40 years (16.8 ± 6.0, mean ± SD) with type 1 diabetes for 2-20 years (8.0 ± 4.2) at centers in the United States (Minneapolis), Canada (Montreal), and France (Paris). At baseline, all patients were normotensive, none had reduced glomerular filtration rate (GFR), and all but eight were normoalbuminuric (NA). All patients had baseline renal biopsies. During the study, patients will have multiple measurements of blood pressure (BP), renal function, albumin excretion rate (AER), glycemia, and other variables, with repeat renal biopsies planned at 5 years after baseline. The 31.3% of the approached patients who agreed to participate were similar in age, diabetes duration, HbA1c, AER, and sex to those refusing participation. Age, diabetes duration, HbA1c, and AER were similar among the three centers, but systolic BP, GFR, renal plasma flow (RPF), and filtration fraction were lower in the Paris center. The 153 patients with hyperfiltration (GFR >130 ml·min-1·1.73 m-2) had greater RPF than those with normal GFR. The eight microalbuminuric patients tended to have longer duration of diabetes but were otherwise similar to the NA patients. The role of these and other variables in determining the development rate of the early lesions of DN over the 5 years between biopsies is the central issue under study.

Original languageEnglish (US)
Pages (from-to)1572-1579
Number of pages8
JournalDiabetes
Volume51
Issue number5
DOIs
StatePublished - Jan 1 2002

Fingerprint

Natural History
Type 1 Diabetes Mellitus
Glomerular Filtration Rate
Diabetic Nephropathies
Renal Plasma Flow
Albumins
Paris
Blood Pressure
Kidney
Biopsy
Type 2 Diabetes Mellitus
France
Canada
Demography

Cite this

The early natural history of nephropathy in type 1 diabetes : I. Study design and baseline characteristics of the study participants. / Mauer, Michael; Drummond, Keith.

In: Diabetes, Vol. 51, No. 5, 01.01.2002, p. 1572-1579.

Research output: Contribution to journalArticle

@article{6b881dadea18451685e6ab233559f45c,
title = "The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants",
abstract = "This report describes the design and baseline demographic and clinical data in the study of the early natural history of diabetic nephropathy (DN) in type 1 diabetes carried out by the International Diabetic Nephropathy Study Group. The study enrolled 243 patients ages 10-40 years (16.8 ± 6.0, mean ± SD) with type 1 diabetes for 2-20 years (8.0 ± 4.2) at centers in the United States (Minneapolis), Canada (Montreal), and France (Paris). At baseline, all patients were normotensive, none had reduced glomerular filtration rate (GFR), and all but eight were normoalbuminuric (NA). All patients had baseline renal biopsies. During the study, patients will have multiple measurements of blood pressure (BP), renal function, albumin excretion rate (AER), glycemia, and other variables, with repeat renal biopsies planned at 5 years after baseline. The 31.3{\%} of the approached patients who agreed to participate were similar in age, diabetes duration, HbA1c, AER, and sex to those refusing participation. Age, diabetes duration, HbA1c, and AER were similar among the three centers, but systolic BP, GFR, renal plasma flow (RPF), and filtration fraction were lower in the Paris center. The 153 patients with hyperfiltration (GFR >130 ml·min-1·1.73 m-2) had greater RPF than those with normal GFR. The eight microalbuminuric patients tended to have longer duration of diabetes but were otherwise similar to the NA patients. The role of these and other variables in determining the development rate of the early lesions of DN over the 5 years between biopsies is the central issue under study.",
author = "Michael Mauer and Keith Drummond",
year = "2002",
month = "1",
day = "1",
doi = "10.2337/diabetes.51.5.1572",
language = "English (US)",
volume = "51",
pages = "1572--1579",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "5",

}

TY - JOUR

T1 - The early natural history of nephropathy in type 1 diabetes

T2 - I. Study design and baseline characteristics of the study participants

AU - Mauer, Michael

AU - Drummond, Keith

PY - 2002/1/1

Y1 - 2002/1/1

N2 - This report describes the design and baseline demographic and clinical data in the study of the early natural history of diabetic nephropathy (DN) in type 1 diabetes carried out by the International Diabetic Nephropathy Study Group. The study enrolled 243 patients ages 10-40 years (16.8 ± 6.0, mean ± SD) with type 1 diabetes for 2-20 years (8.0 ± 4.2) at centers in the United States (Minneapolis), Canada (Montreal), and France (Paris). At baseline, all patients were normotensive, none had reduced glomerular filtration rate (GFR), and all but eight were normoalbuminuric (NA). All patients had baseline renal biopsies. During the study, patients will have multiple measurements of blood pressure (BP), renal function, albumin excretion rate (AER), glycemia, and other variables, with repeat renal biopsies planned at 5 years after baseline. The 31.3% of the approached patients who agreed to participate were similar in age, diabetes duration, HbA1c, AER, and sex to those refusing participation. Age, diabetes duration, HbA1c, and AER were similar among the three centers, but systolic BP, GFR, renal plasma flow (RPF), and filtration fraction were lower in the Paris center. The 153 patients with hyperfiltration (GFR >130 ml·min-1·1.73 m-2) had greater RPF than those with normal GFR. The eight microalbuminuric patients tended to have longer duration of diabetes but were otherwise similar to the NA patients. The role of these and other variables in determining the development rate of the early lesions of DN over the 5 years between biopsies is the central issue under study.

AB - This report describes the design and baseline demographic and clinical data in the study of the early natural history of diabetic nephropathy (DN) in type 1 diabetes carried out by the International Diabetic Nephropathy Study Group. The study enrolled 243 patients ages 10-40 years (16.8 ± 6.0, mean ± SD) with type 1 diabetes for 2-20 years (8.0 ± 4.2) at centers in the United States (Minneapolis), Canada (Montreal), and France (Paris). At baseline, all patients were normotensive, none had reduced glomerular filtration rate (GFR), and all but eight were normoalbuminuric (NA). All patients had baseline renal biopsies. During the study, patients will have multiple measurements of blood pressure (BP), renal function, albumin excretion rate (AER), glycemia, and other variables, with repeat renal biopsies planned at 5 years after baseline. The 31.3% of the approached patients who agreed to participate were similar in age, diabetes duration, HbA1c, AER, and sex to those refusing participation. Age, diabetes duration, HbA1c, and AER were similar among the three centers, but systolic BP, GFR, renal plasma flow (RPF), and filtration fraction were lower in the Paris center. The 153 patients with hyperfiltration (GFR >130 ml·min-1·1.73 m-2) had greater RPF than those with normal GFR. The eight microalbuminuric patients tended to have longer duration of diabetes but were otherwise similar to the NA patients. The role of these and other variables in determining the development rate of the early lesions of DN over the 5 years between biopsies is the central issue under study.

UR - http://www.scopus.com/inward/record.url?scp=0036317169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036317169&partnerID=8YFLogxK

U2 - 10.2337/diabetes.51.5.1572

DO - 10.2337/diabetes.51.5.1572

M3 - Article

C2 - 11978658

AN - SCOPUS:0036317169

VL - 51

SP - 1572

EP - 1579

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 5

ER -